These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19381484)

  • 61. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients.
    Hagiwara N; Toyoda K; Inoue T; Shimada H; Ibayashi S; Iida M; Okada Y
    J Stroke Cerebrovasc Dis; 2007; 16(4):145-52. PubMed ID: 17689410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lack of strong association of Chlamydia pneumoniae and atherosclerosis in a Jordanian population.
    Al-Younes HM; Abu Abeeleh MA; Jaber BM
    J Infect Dev Ctries; 2016 May; 10(5):457-64. PubMed ID: 27249520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of Chlamydophila pneumoniae DNA in peripheral blood mononuclear cells of blood donors in the north-east of Italy.
    Rassu M; Lauro FM; Cazzavillan S; Bonoldi E; Belloni M; Bettini MC; Pilotto A; Mengoli C; Peron A; Zambello R; Scagnelli M; Bertoloni G
    Med Microbiol Immunol; 2001 Dec; 190(3):139-44. PubMed ID: 11827203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis.
    Colpan ME; Attar A; Colpan A; Karahan C; Seckin S; Sargon MF; Egemen N
    J Clin Neurosci; 2004 May; 11(4):389-94. PubMed ID: 15080954
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.
    Deniset JF; Pierce GN
    Fundam Clin Pharmacol; 2010 Oct; 24(5):607-17. PubMed ID: 20653790
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Absence of Chlamydia pneumoniae in brain of vascular dementia patients.
    Wozniak MA; Cookson A; Wilcock GK; Itzhaki RF
    Neurobiol Aging; 2003 Oct; 24(6):761-5. PubMed ID: 12927758
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice.
    Ezzahiri R; Stassen FR; Kurvers HA; van Pul MM; Kitslaar PJ; Bruggeman CA
    Eur J Vasc Endovasc Surg; 2003 Jul; 26(1):88-95. PubMed ID: 12819654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Serological markers of chronic Chlamydia pneumoniae and cytomegalovirus (CMV) infection in patients with peripheral occlusive artery disease--an initial report].
    Rabczyński M; Jakobsche U; Adamiec R
    Przegl Lek; 2007; 64(6):416-8. PubMed ID: 18159850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.
    Droemann D; Rupp J; Goldmann T; Uhlig U; Branscheid D; Vollmer E; Kujath P; Zabel P; Dalhoff K
    Am J Respir Crit Care Med; 2007 Apr; 175(8):791-7. PubMed ID: 17290045
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Infection and atherosclerosis. An alternative view on an outdated hypothesis.
    Stassen FR; Vainas T; Bruggeman CA
    Pharmacol Rep; 2008; 60(1):85-92. PubMed ID: 18276989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?
    Di Pietro M; Schiavoni G; Sessa V; Pallotta F; Costanzo G; Sessa R
    Osteoporos Int; 2013 May; 24(5):1677-82. PubMed ID: 23160916
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice.
    Liuba P; Pesonen E; Paakkari I; Batra S; Andersen L; Forslid A; Ylä-Herttuala S; Persson K; Wadström T; Wang X; Laurini R
    J Vasc Res; 2003; 40(2):115-22. PubMed ID: 12808347
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hyperinsulinemia, lipoprotein (a), and Chlamydia pneumoniae antibodies--are they risk factors or serologic predictors for progression of coronary artery disease?
    Tontsch D; Noll B; Schaefer JR; Herzum M; Maisch B; Goeke B
    Angiology; 2000 Oct; 51(10):831-6. PubMed ID: 11108327
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
    Hahn DL
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):271-88, 291; quiz 291-2. PubMed ID: 10541419
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chlamydia pneumoniae antibodies and markers of inflammation in patients with cardiovascular diseases.
    Kazar J; Kovacova E; Koncova K; Cvachova S; Mongiellova V; Lietava J; Simko F
    Bratisl Lek Listy; 2005; 106(11):341-4. PubMed ID: 16541617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systematic Infection of Chlamydia Pneumoniae.
    Ma Y; Sun J; Che G; Cheng H
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975489
    [TBL] [Abstract][Full Text] [Related]  

  • 78. No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques.
    Halvorsen DS; Karlsen J; Notø AT; Mathiesen EB; Njølstad I; Gutteberg TJ; Vorland LH; Hansen JB
    Int J Cardiol; 2007 May; 117(3):388-94. PubMed ID: 17182139
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells.
    Oksaharju A; Lappalainen J; Tuomainen AM; Pussinen PJ; Puolakkainen M; Kovanen PT; Lindstedt KA
    J Cell Mol Med; 2009 Jan; 13(1):103-13. PubMed ID: 18298659
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.